BDX Q1 2021 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q1 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.3B+25.8% YoY

Gross Profit

$2.7B51.4% margin

Operating Income

$1.2B23.3% margin

Net Income

$1.0B18.9% margin

EPS (Diluted)

$3.35

QoQ Revenue Growth

+11.1%

Cash Flow

Operating Cash Flow

$1.5B

Free Cash Flow

$1.3B

Stock-Based Comp.

$83M

Balance Sheet

Total Assets

$54.7B

Total Liabilities

$30.1B

Stockholders' Equity

$24.7B

Cash & Equivalents

$3.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.3B	$4.2B	+25.8%
Gross Profit	$2.7B	$2.0B	+38.1%
Operating Income	$1.2B	$501M	+147.7%
Net Income	$1.0B	$278M	+260.8%

Revenue Segments

Medical

$2.3B43%

Life Sciences

$2.0B37%

Interventional

$1.1B20%

Geographic Segments

UNITED STATES

$3.1B59%

Non-US

$2.2B41%